Relationship between time in range and corneal nerve fiber loss in asymptomatic patients with type 2 diabetes

被引:7
作者
Zhao, Weijing [1 ,2 ,3 ,4 ,5 ]
Lu, Jingyi [1 ,2 ,3 ,4 ,5 ,6 ]
Zhang, Lei [1 ,2 ,3 ,4 ,5 ]
Lu, Wei [1 ,2 ,3 ,4 ,5 ]
Zhu, Wei [1 ,2 ,3 ,4 ,5 ]
Bao, Yuqian [1 ,2 ,3 ,4 ,5 ]
Zhou, Jian [1 ,2 ,3 ,4 ,5 ,7 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, 600 Yishan Rd, Shanghai 200233, Peoples R China
[2] Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China
[3] Shanghai Key Clin Ctr Metab Dis, Shanghai 200233, Peoples R China
[4] Shanghai Diabet Inst, Shanghai 200233, Peoples R China
[5] Shanghai Key Lab Diabet Mellitus, Shanghai 200233, Peoples R China
[6] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Metab Dis,Shanghai Diabet Inst, Shanghai Key Lab Diabet Mellitus, Shanghai 200233, Peoples R China
[7] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Jinshan Branch, Shanghai 201500, Peoples R China
基金
中国国家自然科学基金;
关键词
Continuous glucose monitoring; Corneal confocal microscopy; Time in range; Type; 2; diabetes; C-PEPTIDE; CONFOCAL MICROSCOPY; SENSORIMOTOR POLYNEUROPATHY; NEUROPATHY; COMPLICATIONS; RETINOPATHY; SENSATION;
D O I
10.1097/CM9.0000000000002140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Corneal confocal microscopy (CCM) is a noninvasive technique to detect early nerve damage of diabetic sensorimotor polyneuropathy (DSPN). Time in range (TIR) is an emerging metric of glycemic control which was reported to be associated with diabetic complications. We sought to explore the relationship between TIR and corneal nerve parameters in asymptomatic patients with type 2 diabetes (T2DM).Methods:In this cross-sectional study, 206 asymptomatic inpatients with T2DM were recruited. After 7 days of continuous glucose monitoring, the TIR was calculated as the percentage of time in the glucose range of 3.9 to 10.0 mmol/L. CCM was performed to determine corneal nerve fiber density, corneal nerve branch density, and corneal nerve fiber length (CNFL). Abnormal CNFL was defined as <= 15.30 mm/mm(2).Results:Abnormal CNFL was found in 30.6% (63/206) of asymptomatic subjects. Linear regression analyses revealed that TIR was positively correlated with CCM parameters both in the crude and adjusted models (all P < 0.05). Each 10% increase in TIR was associated with a 28.2% (95% CI: 0.595-0.866, P = 0.001) decreased risk of abnormal CNFL after adjusting for covariates. With the increase of TIR quartiles, corneal nerve fiber parameters increased significantly (all P for trend <0.01). The receiver operating characteristic curve indicated that the optimal cutoff point of TIR was 77.5% for predicting abnormal CNFL in asymptomatic patients.Conclusions:There is a significant independent correlation between TIR and corneal nerve fiber loss in asymptomatic T2DM patients. TIR may be a useful surrogate marker for early diagnosis of DSPN.
引用
收藏
页码:1978 / 1985
页数:8
相关论文
共 36 条
[1]   Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes A concurrent validity study [J].
Ahmed, Ausma ;
Bril, Vera ;
Orszag, Andrej ;
Paulson, Jenna ;
Yeung, Emily ;
Ngo, Mylan ;
Orlov, Steven ;
Perkins, Bruce A. .
DIABETES CARE, 2012, 35 (04) :821-828
[2]   Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy [J].
Alam, Uazman ;
Jeziorska, Maria ;
Petropoulos, Loannis N. ;
Asghar, Omar ;
Fadavi, Hassan ;
Ponirakis, Georgios ;
Marshall, Andrew ;
Tavakoli, Mitra ;
Boulton, Andrew J. M. ;
Efron, Nathan ;
Malik, Rayaz A. .
PLOS ONE, 2017, 12 (07)
[3]   Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics [J].
Alexander, Charles M. ;
Amiel, Stephanie ;
Beck, Roy ;
Bergenstal, Richard M. ;
Bloomgarden, Zachary ;
Brown, Adam ;
Buckingham, Bruce ;
Cefalu, William T. ;
Close, Kelly L. ;
Chin, Isabel ;
Danne, Thomas ;
DeSalvo, Daniel ;
Dickinson, Jane K. ;
Fitts, Emily ;
Frier, Brian ;
Gabbay, Robert A. ;
Grunberger, George ;
Hirsch, Irl ;
Home, Philip ;
Kowalski, Aaron ;
Laffel, Lori ;
McCall, Anthony ;
Parkin, Christopher G. ;
Peters, Anne L. ;
Ratner, Robert ;
Van der Schueren, Bart ;
Wood, Richard .
DIABETES CARE, 2018, 41 (06) :E92-E94
[4]  
Ang Lynn, 2018, Diabetes Spectr, V31, P224, DOI 10.2337/ds18-0036
[5]   Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials [J].
Ang, Lynn ;
Jaiswal, Mamta ;
Martin, Catherine ;
Pop-Busui, Rodica .
CURRENT DIABETES REPORTS, 2014, 14 (09) :1-15
[6]   Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials [J].
Beck, Roy W. ;
Bergenstal, Richard M. ;
Riddlesworth, Tonya D. ;
Kollman, Craig ;
Li, Zhaomian ;
Brown, Adam S. ;
Close, Kelly L. .
DIABETES CARE, 2019, 42 (03) :400-405
[7]   Use of Continuous Glucose Monitoring as an Outcome Measure in Clinical Trials [J].
Beck, Roy W. ;
Calhoun, Peter ;
Kollman, Craig .
DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (10) :877-882
[8]   Corneal nerve fibre damage precedes diabetic retinopathy in patients with Type2 diabetes mellitus [J].
Bitirgen, G. ;
Ozkagnici, A. ;
Malik, R. A. ;
Kerimoglu, H. .
DIABETIC MEDICINE, 2014, 31 (04) :431-438
[9]   How does CKD affect HbA1c? [J].
Bloomgarden, Zachary ;
Handelsman, Yehuda .
JOURNAL OF DIABETES, 2018, 10 (04) :270-270
[10]   Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy [J].
Bril, V ;
Perkins, BA .
DIABETES CARE, 2002, 25 (11) :2048-2052